In this study, we report for the first time, a favorable association between improved clinical outcomes in ICI‐treated NSCLC and transcriptional upregulation of CXCL13 considered a surrogate marker of TLS.17, 23, 24, 25. Here, CXCL13 is linked to non-small cell lung carcinoma.